Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

EPA fines Mosaic Fertilizer over hazardous waste handling

8 October 2015 Business

US Environmental Protection Agency agrees settlement contract including $8m penalty and $800m in investments

Controversial new trade deal finalised

8 October 2015 Business

The Trans-Pacific Partnership could raise the price of medicines, especially in developing nations

Bristol-Myers-Squibb fined for alleged Chinese bribes

7 October 2015 Business

US Securities and Exchange Commission accepts $14m settlement for charges covering the last five years

Safety board fills in details of deadly DuPont leak

5 October 2015 Business

In interim investigation has outlined the events and safety failings leading to a methyl mercaptan release that killed four workers

Drax pulls out of carbon capture power station plans

28 September 2015 Business

Energy giant says government policies have slashed income and made carbon capture project too costly

Bayer CropScience pays $5.6m to settle 2008 accident charges

25 September 2015 Business

Fine will fund environmental projects, fire department upgrades and wastewater treatment facilities

Cosmetics deals push skin 3D bioprinting

24 September 2015 Business

Interest for testing from L’Oréal, BASF and Procter & Gamble could be a stepping stone towards bespoke organs

Amgen expands cardiovascular portfolio with Dezima acquisition

18 September 2015 Business

Amgen’s $300 million purchase of Dutch biotech gives the company the potential to offer more varied treatment options to lower cholesterol

Merger fever sweeps pharma

10 September 2015 Business

The life sciences sector has been gripped by a mergers and acquisition frenzy, and it looks set to continue. But what does it mean for the industry?

Syngenta to sell off seed business after failed Monsanto takeover

8 September 2015 Business

Syngenta to restore shareholder confidence following a series of failed takeover bids by Monsanto

Cancer Drugs Fund axes 23 treatments

7 September 2015 Business

The UK government has cut down the list of cancer therapies it will pay for through the Cancer Drugs Fund

Novartis to buy experimental MS drug from GSK in $1bn deal

4 September 2015 Business

Deal will help to bolster Novartis's pipeline for neurological disorder treatments

US regulator reprimands Cepheid for norovirus diagnosis tool quality

4 September 2015 Business

Diagnostics firm has 15 days to respond to violations laid out by regulator

FDA takes action to remove biosimilars roadblock

1 September 2015 Business

The US Food and Drug Administration proposes system to name biosimilar drugs

Syngenta fends off Monsanto takeover bid

27 August 2015 Business

Unmoving objection to merger leads US giant to drop pursuit

Job cuts at Lundbeck and DSM

27 August 2015 Business

Each cutting around 1000 roles in reorganisation efforts

Female sexual desire drug approved

26 August 2015 Business

Concerns raised over efficacy, side effects and use of advocacy campaigning to influence regulatory decisions

Indian pharma under increased regulatory scrutiny

21 August 2015 Business

Import bans and tightened rules pose a significant challenge for companies

Porous pills could be largest industrial 3D printing use

20 August 2015 Business

US grants first-of-a-kind approval for Aprecia’s epilepsy tablets exploiting porous structure

Greek crisis puts pressure on pharmaceuticals

17 August 2015 Business

Public spending cuts and capital restrictions on banks have exacerbated drug supply problems in Greece

Deadly chemical blast at Chinese port

14 August 2015 Business

Explosion at warehouse in Tianjin kills at least 50 and injures hundreds, while ammonia leak sparks mass evacuations in Nanchong

No one should be denied medication

14 August 2015 Business

Exclusive interview
 with Yusuf Hamied
, chairman of Indian generic drugmaker Cipla

Shire makes hostile bid for Baxalta

10 August 2015 Business

Recently spun-out from Baxter, Baxalta is resisting the deal, saying it wants time to prove its true value

Grabbing slices of the immuno-oncology pie

5 August 2015 Business

Another spate of immuno-oncology dealmaking adds to fervour in pharma’s ‘hottest space’

Berry plastics to buy Avintiv for $2.5bn

4 August 2015 Business

Deal helps Berry diversify from food packaging into speciality medical materials